MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,157,687
Free Cash flow
-$475,987
Unit: Dollar
Positive Cash Flow Breakdown
Share-based compensation
Depreciation and amortization
Accrued royalties and expenses
Others
Negative Cash Flow Breakdown
Accrued bonuses and commissions
Accounts payable
Accounts receivable, net
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Paid-in-kind interest
0
606,197
598,172
995,244
Accounts receivable related parties
0
0
-9,081
-31,485
Accounts payable related parties
0
-2,338
-5,017
1,442
Net income (loss)
5,739
-1,610,158
-30,412,108
-5,545,781
Depreciation and amortization
1,206,363
668,396
1,038,928
2,238,641
(gain) loss on disposal of property and equipment
1,376
1,841,120
26,472,407
-
Share-based compensation
2,524,645
1,181,973
1,232,445
2,740,343
Change in fair value of earnout liabilities
-
-
-
0
Noncash lease expense
166,356
79,087
86,527
359,758
Back-end fee
359,067
201,411
201,411
377,490
Accretion of finance liabilities
53,160
28,157
33,481
86,541
Amortization and write-off of debt issuance costs
147,083
73,542
73,542
132,821
Accounts receivable, net
700,576
-30,269
270,045
-125,086
Inventory, net
-358,005
655,265
-8,278
1,130,775
Prepaid and other assets
-254,547
194,751
-394,551
76,285
Gain on disposal of property and equipment
-
-
-
9,674
Accounts payable
-937,318
1,173,967
-317,504
-42,464
Accrued royalties and expenses
898,597
-111,572
86,691
317,076
Accrued bonuses and commissions
-5,762,706
248,351
2,459,004
-579,389
Gain on disposal of property and equipment
-
0
9,674
-
Operating lease liabilities
-169,250
-80,533
-84,859
-361,513
Credit loss expense
141,000
50,000
165,199
294,034
Inventory obsolescence
130,822
92,474
117,615
371,957
Share of losses from equity method investments
-896,155
-324,734
-288,642
-339,090
Net cash provided by (used in) operating activities
-426,935
3,945,061
2,176,441
665,127
Proceeds from disposal of property and equipment
0
0
0
60,000
Purchases of intangible assets
0
0
0
23,452
Investment in equity securities
0
2,363,118
2,361,307
3,538,217
Carepics acquisition
0
0
0
2,122,146
Purchases of property and equipment
49,052
82,159
1,059,483
3,484,008
Pay off line of credit
-
-
-
0
Net cash used in investing activities
-49,052
-2,445,277
-3,420,790
-9,107,823
Loan proceeds, net of debt issuance costs of zero in 2026 and 228,183 in 2025
0
0
0
12,021,817
Pay off debt assumed in carepics acquisition
0
0
0
1,650,000
Net settlement of equity-based awards
-525,700
217,427
-71,749
-692,672
Cash payment of finance and earnout liabilities
156,000
78,000
703,000
156,000
Net cash provided by (used in) financing activities
-681,700
139,427
-774,749
9,523,145
Net increase (decrease) in cash and cash equivalents
-1,157,687
1,639,211
-2,019,098
1,080,449
Cash and cash equivalents, beginning of period
16,578,857
14,939,646
15,878,295
-
Cash and cash equivalents, end of period
15,421,170
16,578,857
14,939,646
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash and cash...
-$1,157,687
(-207.15%↓ Y/Y)
Share-based compensation
$2,524,645
(-7.87%↓ Y/Y)
Depreciation and
amortization
$1,206,363
(-46.11%↓ Y/Y)
Accrued royalties and
expenses
$898,597
(183.40%↑ Y/Y)
Share of losses from
equity method...
-$896,155
(-164.28%↓ Y/Y)
Back-end fee
$359,067
(-4.88%↓ Y/Y)
Inventory, net
-$358,005
(-131.66%↓ Y/Y)
Prepaid and other assets
-$254,547
(-433.68%↓ Y/Y)
Noncash lease expense
$166,356
(-53.76%↓ Y/Y)
Amortization and write-off of
debt issuance costs
$147,083
(10.74%↑ Y/Y)
Credit loss expense
$141,000
(-52.05%↓ Y/Y)
Inventory obsolescence
$130,822
(-64.83%↓ Y/Y)
Accretion of finance
liabilities
$53,160
(-38.57%↓ Y/Y)
Net income (loss)
$5,739
(100.10%↑ Y/Y)
(gain) loss on disposal
of property and...
$1,376
Net cash provided by
(used in) financing...
-$681,700
(-107.16%↓ Y/Y)
Net cash provided by
(used in) operating...
-$426,935
(-164.19%↓ Y/Y)
Net cash used in
investing activities
-$49,052
(99.46%↑ Y/Y)
Canceled cashflow
$7,142,915
Net settlement of
equity-based awards
-$525,700
(24.11%↑ Y/Y)
Cash payment of
finance and earnout...
$156,000
(0.00%↑ Y/Y)
Accrued bonuses and
commissions
-$5,762,706
(-894.62%↓ Y/Y)
Purchases of property and
equipment
$49,052
(-98.59%↓ Y/Y)
Accounts payable
-$937,318
(-2107.32%↓ Y/Y)
Accounts receivable, net
$700,576
(660.08%↑ Y/Y)
Operating lease
liabilities
-$169,250
(53.18%↑ Y/Y)
Buy us a coffee
Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc. (SMTI)